ArrePath
PrivateLast Round
VC Round
Jun 23, 2025
Total Funding Raised
$24.97M
Company Overview
ArrePath is a biotechnology company that operates a drug discovery platform intended to develop antimicrobial resistance therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArrePath Comps
Public and private peers based on sector, stage, and business model.
ArrePath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 23, 2025 | ||||
| Grant | Apr 2, 2025 | ||||
| Grant | Nov 19, 2024 | ||||
| Seed | Mar 3, 2022 |
ArrePath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PTX Capital | Seed |
| Nor'easter Ventures | VC Round, Seed |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| Boehringer Ingelheim Venture Fund | VC Round, Seed |
| Viva BioInnovator | Seed |
| Ab Magnitude Ventures Group | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Monthly visitors increased 35% MoM.
- Jan 1, 2026
Monthly visitors increased 47% MoM.
ArrePath Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ArrePath's valuation, stock price, and market status.
